PHARM Connect Congress
News Mar 18, 2011
The quality of the congress was a direct result of its exclusivity. The Programme Advisory Committee ensured the conference programme, which was presented by the most prominent, leading European pharma industry professionals, was of the highest relevance and covered the most up-to-date market insights into R&D, production, engineering, supply chain and quality management-related topics.
Moreover, the CORINTHIA Grand Hotel Royal offered the perfect setting for local and international solution-providers to present their products and services directly to key decision-makers. Several weeks in advance the online TEG Meeting Scheduler system was made available to every solution-provider and the 300 delegates attending from 13 countries. Through the Meeting Scheduler over 800 pre-scheduled meetings were arranged to gather strategic intelligence and business contacts, aims which are critical to achieve to stay ahead in today’s competitive marketplace.
Furthermore, numerous leading local and regional media partners and associations promoted the event throughout Central and Eastern Europe, an exposure which ensured the regional focus of the congress. Tamás Szolyák, Chairman of the Hungarian Association of Innovative
Pharmaceutical Manufacturers (AIPM) and General Manager of Novartis Hungary, opened the cocktail reception with a welcome speech which gathered together the majority of the delegates and solution providers to network and benchmark with each other in a relaxed atmosphere.
In addition, the congress provided an exclusive opportunity for 110 delegates to take part in a specially organised plant excursion to the high-tech sanofi-aventis/ Chinoin plant in Budapest, one of the most modern and technologically advanced facilities in the region.
Ariel Lasry, EMEA Vertical Leader, Life Sciences, Rockwell Automation, who attended as a vendor, was one of many to be extremely impressed with what he had experienced: “The event was very well-balanced between networking, lead generation and also very professional speeches. I think the staff are very experienced and bring the right people to the table. This concept is, I think, the only concept that works for the life science industry.”
Do not miss your opportunity to join the second edition of the PHARM Connect Congress to network, establish connections, exchange ideas and gain knowledge; every single square metre of space was sold out at the first edition!
The ideal drug is one that only affects the exact cells and neurons it is designed to treat, without unwanted side effects. This concept is especially important when treating the delicate and complex human brain. Now, scientists have revealed a mechanism that could lead to this kind of long-sought specificity for treatments of strokes and seizures.READ MORE